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Paying Attention
to Neglected
Diseases
Tropical diseases are drug development’s
poorest relations. Until recently, these dis-
eases have been so ignored that “people
even refer to them as neglected neglected
diseases,” says Charles Gardner, associate
director for health equity with the
Rockefeller Foundation, which funds a
number of initiatives focused on diseases
of the poor. In July 2003, a new interna-
tional collaboration was launched to rein-
vigorate research and development on
treatments for tropical diseases.
The Drugs for Neglected Diseases
Initiative (DNDi) was spearheaded by the
volunteer medical group Médecins Sans
Frontières (MSF) and five other partners:
France’s Institut Pasteur, the Malaysian
Ministry of Health, Brazil’s Oswaldo Cruz
Foundation, the Kenya Medical Research
Institute, and the Indian Council of
Medical Research. The nonprofit initiative
was designed to revitalize drug develop-
ment as a public responsibility rather than
a strictly market-driven enterprise. 
Governments and the pharmaceutical
industry are pitching in, with some already
providing money (the European Union)
and expertise (Merck & Company and
Novartis Pharmaceuticals). DNDi’s opera-
tions, headquartered in Geneva, will be
distributed throughout the developing and
developed world, with the goal of support-
ing a budding collaboration on health care
research and application between devel-
oped and developing nations.
DNDi is in the process of building a
portfolio that will contain a balanced mix
of short-, medium-, and long-term proj-
ects targeting neglected diseases. DNDi’s
initial drug development efforts are aimed
at chloroquine-resistant malaria, human
African trypanosomiasis (sleeping sick-
ness), visceral leishmaniasis (also called
kala-azar), and Chagas disease. According
to the World Health Organization, malar-
ia affects more than one-third of the
world’s population and kills more than 1
million children each year. Sleeping sick-
ness afflicts half a million people and
threatens more than 60 million in sub-
Saharan Africa. Worldwide, about 12 mil-
lion people suffer from visceral leishmani-
asis, and 200 million are at risk of con-
tracting it. Chagas disease afflicts an esti-
mated 18 million in Latin America and
threatens about a quarter of the region’s
population. All of these diseases are trans-
mitted by biting insects. Chagas disease is
also transmitted congenitally and through
transfusion with infected blood.
Tropical diseases can be very difficult
to treat, says Martin John Rogers, a pro-
gram officer with the Parasitology and
International Programs Branch of the
National Institute of Allergy and
Infectious Diseases, because of the disease
progression within human beings. Initial
symptoms are often nonexistent, minor, or
nonspecific, and by the onset of severe
symptoms—sometimes decades after
infection—the disease is so far advanced
that treatment is either futile or possibly
fatal in itself. Moreover, drug delivery
techniques and treatment regimens are
often impractical in rural and/or impover-
ished areas, and patients may need to trav-
el great distances, leaving their families and
lands untended, to reach the nearest health
center. DNDi hopes to investigate and
develop less toxic, more effective, and
more practical treatments adapted to
patient needs. 
The global burden of neglected dis-
eases has increased, some say, because
pharmaceutical companies are loath to
spend money on unprofitable drugs.
Furthermore,  the first wave of tropical
medicine was driven by the self-interest of
colonial powers, according to Mohammed
Hassar, director of the Institut Pasteur du
Maroc in Casablanca. “The health of sol-
diers, the colonists, and the local popula-
tion was vital for the success of the colo-
nization,” Hassar says. But when colonial
powers withdrew, they also took their
money, medical expertise, and concern
about local conditions. In the post-colo-
nial world, the countries where neglected
diseases have made a comeback must pick
up the slack. “I believe DNDi is a good
start,” says Hassar.
Early reactions from researchers
are encouraging. By July 2003,
when DNDi was established as a
foundation, it had received 71
project proposals from its first call
for letters of interest from the sci-
entific community. Early next year,
work will commence on selected
projects. Says DNDi spokesperson
Jaya Banerji, “The organization is
still in the process of building its
portfolio of drug research and
development projects and will soon
be issuing a second call for propos-
als aimed at its target diseases.” The
success of these projects depends
on the collaboration of scientists
across the world and will enable
DNDi to achieve its vision of
improving the quality of life and
health of people suffering from
neglected diseases in poorer coun-
tries. –Valerie J. Brown
Instead of calling it environment and conservation, let’s call it public health once in a while. 
Angela Rooney
Environmental Quality and Social Justice in Urban America (1974)
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PHARMACEUTICALS
Awake to the possibilities. A new initiative seeks to drive drug development for neglected diseases
such as sleeping sickness.Fish on Prozac
The U.S. EPA is in the process of deciding whether
regulations are needed for pharmaceuticals in
water supplies. Studies now coming through the
research pipeline may help the EPA with its
decision. In a study
presented at the
November 2003
annual meeting of
the Society of
Environmental
Toxicology and
Chemistry, Baylor
University’s Bryan
Brooks determined
that fluoxetine hydrochloride (the active
ingredient in the antidepressant Prozac) excreted
into the sewer system is accumulating in the
tissues of bluegill caught in nearby Denton Creek.
Waste treatment systems often are ill-equipped to
remove such contaminants from sewage. 
Healing Afghanistan’s
Environment
At the request of the Transitional Islamic
Government of Afghanistan, an international
team largely funded by the European Commission
embarked in October 2003 on a program to
promote environmental governance and support
rehabilitation of Afghanistan’s war-ravaged
environment and famished population. The 
US$5 million-plus, two-phase program will
address priorities set in the country’s national
development budget and in UNEP’s 2003
Afghanistan: Post-Conflict Environmental
Assessment [see “Environmental Triage in
Afghanistan,” EHP 111:A470–A473 (2003)].
The program will first focus on organizing and
building capacity for a specialized environmental
Afghan public administration. Beginning in 2004,
phase two of the project will launch efforts
directed toward strengthening the Department
of the Environment, establishing protected areas,
and integrating environmental education into
Afghan schools and universities.
Burning Banned for Irish
Hospitals
In response to concerns over health effects linked
to air pollutants such as dioxin and mercury
emitted during the incineration of hospital waste,
the Republic of Ireland and Northern Ireland joined
in September 2003 to require
nonburning technologies for
treating the approximately
9,500 tons of medical
waste the two neighbors
produce annually. 
The Joint Waste
Management Board of
Ireland signed a 10-year
contract to have 95% of
the two countries’ hospital
waste sterilized using steam-
based systems, which work as
effectively as burning and can be more
cost-effective. The remainder—which includes
biohazardous matter—will be incinerated abroad.
Forum
Environmental Health Perspectives • VVOLUME 112 | NUMBER 1 | January 2004 A 25
The Beat
An Affordable
Antimalarial
In a blend of new and old, a plant-derived
drug called artemisinin that the ancient
Chinese used to treat fever is now being
used effectively against drug-resistant
malaria. When derived from the plant
Artemisia annua, artemisinin costs about
$1.50 per adult dose—unaffordable in
much of Africa, where most malaria deaths
occur. But while naturally derived
artemisinin is too costly for many malaria
sufferers in devel-
oping nations, an
elaborate genetic
engineering project
may offer hope for
a more affordable
artemisinin-based
therapy.
According to
the World Health
Organization, mal-
aria kills more than
1 million annually.
The malaria parasite
Plasmodium falci-
parum has evolved
resistance to older
medicines, and arte-
misinin and its
derivatives are con-
sidered essential to
fighting the disease. 
In  April 2003, the volunteer medical
group Médecins Sans Frontières asked inter-
national donors to promote “rapid imple-
mentation of artemisinin-based combination
therapy (ACT), a proven treatment that is
being promoted by the World Health Organ-
ization.” ACT works by pairing artemisinin
with traditional antimalarials that act by
other mechanisms.
In a project reported in the July 2003
Nature Biotechnology, Berkeley professor of
chemical engineering Jay Keasling and col-
leagues inserted 10 genes into the common
bacterium  Escherichia coli, creating a
microbe that makes amorphadiene, an
artemisinin precursor  that is easily convert-
ed to the drug. The transferred genes con-
vert a chemical commonly found in E. coli,
acetyl co-enzyme A, into amorphadiene.
Instead of enhancing the E. coli genes that
normally produce amorphadiene, the sub-
stitute pathway becomes a second, much
larger source of amorphadiene.
One key to success has been balancing
the multistep biosynthesis of amorphadiene
in the bacteria, says Keasling. Some inter-
mediate compounds in the synthesis,
including isopentanyl pyrophosphate (IPP),
are toxic to E. coli at high concentrations.
It’s  critical to carefully balance the genes
that synthesize and utilize IPP to ensure
that IPP is quickly converted to amorphadi-
ene before it kills the E. coli, Keasling adds. 
The transformed E. coli produce about
a gram of precursor—enough for one adult
dose of treatment—per liter of solution. By
fine-tuning the bacteria and perhaps adding
more genes, Keasling hopes to reach 50
grams per liter. “If we were to get some
high, but reasonable, yields, we could be
producing one treatment for twelve cents,”
he says. 
The report is “a
landmark paper,”
says Jörg Bohl-
mann, an assistant
professor in the
Biotechnology
Laboratory at the
University of Brit-
ish Columbia. In-
stead of transfer-
ring just one gene,
he says, Keasling
moved enough
genes to create an
entire new meta-
bolic pathway in
E. coli, thereby
raising the yield of
the drug precur-
sor. Plants, he
notes, are quite variable in their produc-
tion of specific chemicals. “If the plant has
the best production at a certain stage of
development, or in a certain part of the tis-
sue, or under certain environmental condi-
tions . . . Keasling can now control the
conditions of production in E. coli” to
maximize yield. 
The transformed bacteria may be use-
ful against other diseases besides malaria,
says Keasling. Artemisinin is one of
roughly 50,000 isoprenoid chemicals that
have evolved to fight pathogens and para-
sites in plants, microbes, and some marine
organisms. Other isoprenoids include the
flavoring menthol, carotenoids (useful for
combating ultraviolet damage), and Taxol
(an anticancer agent derived from the
Pacific yew). 
Keasling says the engineered E. coli
could be further transformed to produce
other isoprenoid chemicals: “A company
could tweak the bacteria a bit, add any
number of plant genes involved in the
chemical of interest, and get pretty much
any isoprenoid.” –David J. Tenenbaum
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ENVIRONMENTAL MEDICINE
Concocting a cure. Researchers are using genes
inserted into E.coli to synthesize a precursor of
artemisinin, used to treat malaria. W
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Colombia Defies
Court on Coca
An aerial glyphosate-based herbicide spray-
ing program, part of the U.S. antinarcotics
effort in Colombia, has successfully reduced
that nation’s hectarage of coca plants. But
critics of the program say its environmental
and health costs are not receiving enough
attention. And although Colombia’s second
highest court, the Administrative
Tribunal of Cundinamarca, declared
in June 2003 that the spraying pro-
gram was too dangerous and must be
suspended until the Colombian gov-
ernment conducts studies to deter-
mine its environmental and health
effects, the government is defying the
order and has continued spraying. 
Last year, Congress ordered the
State Department to consult with the
U.S. Environmental Protection
Agency (EPA) in assessing the use of
glyphosate in Colombia. EPA assis-
tant administrator Stephen L.
Johnson told the State Department
that glyphosate as used in Roundup, a
popular U.S. commercial product,
has “no unreasonable adverse effects,” but
also noted that the particular glyphosate
formulations being used in Colombia can
cause acute eye irritation. He suggested
steps be taken to mitigate drift. 
Rachel Massey, a research associate at the
Tufts University Global Development and
Environment Institute, contends the effects
of the large-scale uses and manners of deliv-
ery that are being employed in Colombia are
unknown. Further, says Astrid Puentes, a
Colombian lawyer now working as legal
director for the Interamerican Association
for Environmental Defense in Oakland,
California, the EPA has
not certified that the par-
ticular glyphosate mixture being sprayed is
being used in accordance with EPA label
requirements, as Congress stipulated.
The spraying is being done by fixed-
wing aircraft, resulting in imprecise applica-
tions. Massey says the spray has wrought
economic damage on subsistence farmers
who are growing crops near coca plants.
The spray also kills native species growing
nearby, she says: “There are some very rare,
delicate, and valuable species that are found
only in those areas.”
Puentes says that plenty of evidence sug-
gests the spraying is also harming people.
Her organization receives informa-
tion and photos from nongovern-
mental organizations such as
Witness for Peace, an international
human rights group with an office
in Colombia. “People say they’re
suffering from skin problems and
other health impacts, especially
among children,” she says.
Puentes argues that the govern-
ment must comply with the court order to
suspend the spraying. She says the govern-
ment must also assess the true environmen-
tal and health consequences of the spraying
program. “One of the excuses the govern-
ment mentions for not implementing these
studies is [Colombia’s ongoing] civil war,”
she says. “But the civil war does not give the
government the right to harm all these
innocent people, especially children.
Protecting the human health and the envi-
ronment and health should be the govern-
ment’s priority.” –Richard Dahl
Tidal Turbines: Wave 
of the Future?
Tidal power plants are an attractive energy option because they don’t
shut down at night (like solar plants) and aren’t dependent on annu-
al rainfall (like freshwater hydropower plants). However, large tidal
installations like the massive 240-megawatt tidal dam across the
mouth of La Rance estuary in France can modify currents, silt flows,
and shoreline habitats. A new generation of technology may offer a
less environmentally intrusive way to harness limitless, renewable
power from the sea. 
In September 2003, a subsea turbine manufactured by research
and development firm Hammerfest Strøm was anchored in Norway’s
Kvalsund Channel and began generating electricity for the small near-
by city of Hammerfest. The submerged turbine looks like a cross
between an airplane propeller and a windmill, with three 10-meter
blades that turn with the tides to produce up to 300 kilowatts (kW)
of electricity, enough to light and heat about 35 Norwegian homes.
If the pilot project is successful, Hammerfest Strøm plans to install up
to 20 additional turbines in the area that would produce a minimum
of 700 kW each.
The Hammerfest Strøm turbine rests on 20-meter tripods
anchored to the sea floor. “If one could extrapolate from the experi-
ence of offshore wind power, for which we have a bit more experi-
ence, the installation period is disruptive but not damaging,” says
Rick Sellers, head of the Renewable Energy Unit of the International
Energy Agency in Paris. Fish concentrations may even increase
around such installations because they serve as artificial reefs, provid-
ing habitat for algae and other organisms that fish eat.
According to project leader Bjørn Bekken, the blades of the
Hammerfest Strøm turbine do not change the waterflow, so they
don’t impede silt or nutrient flows. He adds that the blades turn so
slowly (about 7 revolutions per minute) that marine mammals and
fish should be able to avoid them, and the blade’s leading edges are
rounded to minimize injury if a collision does occur. 
Not all tidal power plants have large exposed blades or are rigidly
attached to the sea floor. AquaEnergy Group of Mercer Island,
Washington, develops offshore power plants using floating buoys that
convert the bobbing of the waves into a high-pressure flow that pow-
ers an enclosed generator. The 85-foot buoys, which have been test-
ed in the North Sea, produce about 80–250 kW each. “They’re no
different than navigational buoys in their impact on the environ-
ment,” says AquaEnergy CEO and president Alla Weinstein. 
In Norway, current environmental policy does not allow the con-
struction of any more major hydropower plants, the country’s only
current source of electricity. Norwegians will thus have to look else-
where to increase or replace generating capacity in the future. “I think
it’s very important to start looking at alternative sources of energy like
tidal power,” says Bekken. “Once we pass peak production of fossil
day, and energy prices will go up.” –Kris Freeman
ENERGY
POLICY
Deadly defiance. Despite agricultural damage,
human health effects, and a court order, Colombia
continues to spray herbicides to combat illegal drugs.
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A Cool $30 Million Pledged
for Russian Arctic
Russia’s vast Arctic region is heavily polluted with
heavy metals and spilled petroleum linked to the
area’s huge mining and fuel extraction operations,
radioactive materials leaking from aging nuclear
power plants, industrial chemical runoff, and other
hazards. In October
2003, a coalition led
by the London-based
nongovernmental
Advisory Committee
on Protection of the
Sea announced a
new campaign to
help restore the region
with the aid of US$30
million donated by
international agencies
and governments.
Initially the campaign
will focus on educating
potential investors on
investing in the development of bio-based
technologies for cleaning up petroleum, mining
waste, and radioactive materials. Supporters of the
campaign hope to remediate abandoned military
bases and to bring indigenous peoples into the
project as stakeholders.
AIDS Crops Agricultural
Output
The UN Food and Agriculture Organization (FAO)
and Joint UN Programme on HIV/AIDS have
announced the release of a landmark report on
the toll HIV/AIDS is taking on agricultural output
in developing countries, especially in sub-Saharan
Africa, where most of the region’s 30 million HIV
sufferers live in agricultural areas and up to 80%
of the population may depend on farming for
their subsistence. According to the FAO, HIV/AIDS
is depleting such regions of their agricultural
labor force for generations to come. Kenya,
Mozambique, Tanzania, Uganda, and Zimbabwe
are among the African countries hardest hit in their
agricultural labor force and suffering the worst
from what the FAO terms “food emergencies.”
U.S. EPA Says ¡Hola!
In fall of 2003 the U.S. EPA introduced a six-week
Spanish-language radio campaign to be aired
throughout the U.S. and Puerto Rico
on the Hispanic Radio Network, which
boasts 162 station affiliates and the
potential to reach 90% of the U.S.
Hispanic radio audience. The
campaign is part of the EPA National
Hispanic Outreach Strategy to involve the
Hispanic-American community in helping
to clean up and conserve the environment.
Segments, which will run during the
network’s Planeta Azul (Blue Planet)
program, give steps communities can
take to improve quality of life, with topics
ranging from children’s health issues to water
conservation to pesticide use. The radio spots will
be complemented with columns to be published in
90 Hispanic newspapers across the country.
Humanitarian Resource Institute
Emerging Infectious Disease Network
ehpnet
Through its communications and advocacy efforts, the nonprofit
Humanitarian Resource Institute (HRI) coordinates international health
and quality-of-life initiatives in a number of wide-ranging areas, and
endeavors to foster multilateral cooperation among countries. One of
HRI’s program areas centers on building awareness of emerging infec-
tious diseases. To do this, the institute has established the Emerging
Infectious Disease Network, a collaboration of international medical,
veterinary, and scientific experts who share information and engage in
academic discussion. At http://www.humanitarian.net/eidnet/, HRI
provides a ever-expanding collection of international information
resources on the growing threat of emerging infectious diseases. 
The introductory page of the section has a link to the HRI aca-
demic discussion platform, an online forum that provides access to
briefings, educational materials, articles, and other resources on the
subjects of agricultural and public health infrastructure protection.
Interested parties must register online to access this forum. Access cur-
rently is limited to public health administrations, university research
departments, government facilities, and military programs.
Under the In The Spotlight header of the introductory page are
links to reference libraries developed for specific diseases including
West Nile virus, foot-and-mouth disease, and transmissible spongiform
encephalopathies.
These libraries con-
tain comprehensive
lists of links to information on the tracking of these diseases in the
United States, as well as to related news articles, webcasts, and other
Internet-based media from public, international, and U.S. government
agency sources. Also listed are links to the homepage of the Centers
for Disease Control and Prevention Division of Health Care Quality
Promotion and to the U.S. Department of Health and Human Services’
GlobalHealth.gov website.
Under the Outbreaks: In The News header, visitors will find links to
articles about biodefense and epidemiological tracking related to spe-
cific diseases including influenza, monkeypox, SARS, West Nile virus,
and foot-and-mouth disease, which have recently been capturing
headlines and public attention around the globe. The Also In The News
section of this page features links to recent articles on related topics
such as veterinary medicine and the threat of chemical and biological
terrorism. Also included here are links to online courses developed for
medical and veterinary professionals by HRI.
More general information related to emerging infectious diseases
can be found at the bottom of the main page. The General
Information section provides a list of links to federal and internation-
al health data resources including health alerts and advisories, the
journal  Emerging Infectious Diseases, and the homepage for the
National Center for Infectious Diseases of the Centers for Disease
Control and Prevention. Also within this section are links to the World
Health Organization (WHO) Global Outbreak Alert & Response
Network, the WHO Department of Communicable Disease Surveillance
and Response, the Weekly Epidemiological Record, and other WHO
resources. The General Veterinary Research & Publications section pro-
vides links to the websites of, among others, the World Organization
for Animal Health and the U.S. Department of Agriculture Center for
Emerging Issues. –Erin E. Dooley